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Introduction: Lower cerebral blood flow (CBF) is associated with cardiovascular disease
and vascular risk factors, and is increasingly acknowledged as an important contributor
to cognitive decline and dementia. In this cross-sectional study, we examined the
association between CBF and cognitive functioning in a community-based, multi-ethnic
cohort.
Methods: From the SABRE (Southall and Brent Revisited) study, we included 214
European, 151 South Asian and 87 African Caribbean participants (71 ± 5 years;
39%F). We used 3T pseudo-continuous arterial spin labeling to estimate whole-brain,
hematocrit corrected CBF. We measured global cognition and three cognitive domains
(memory, executive functioning/attention and language) with a neuropsychological test
battery. Associations were investigated using linear regression analyses, adjusted for
demographic variables, vascular risk factors and MRI measures.
Results: Across groups, we found an association between higher CBF and
better performance on executive functioning/attention (standardized ß [stß] = 0.11,
p < 0.05). Stratification for ethnicity showed associations between higher CBF
and better performance on memory and executive functioning/attention in the white
European group (stß = 0.14; p < 0.05 and stß = 0.18; p < 0.01 respectively),
associations were weaker in the South Asian and African Caribbean groups.
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Conclusions: In a multi-ethnic community-based cohort we showed modest
associations between CBF and cognitive functioning. In particular, we found
an association between higher CBF and better performance on executive
functioning/attention and memory in the white European group. The observations
are consistent with the proposed role of cerebral hemodynamics in cognitive decline.
Keywords: cerebral perfusion, arterial spin labeling, cognition, neuropsychology, vascular risk factors, ethnicity
INTRODUCTION
Hemodynamic abnormalities, such as lower cerebral blood flow
(CBF), are associated with cardiovascular disease and vascular
risk factors, and are increasingly acknowledged as an important
contributor to cognitive decline and dementia (Ott et al., 1999;
Whitmer et al., 2005; Binnewijzend et al., 2013; Bangen et al.,
2014; Wolters et al., 2016; Leeuwis et al., 2017). Earlier studies
have shown that cerebral blood flow (CBF) is lower in patients
with cognitive impairment or dementia, compared to healthy
controls (Binnewijzend et al., 2013, 2015). CBF mapping can
be accomplished with a non-invasive MRI-technique, arterial
spin labeling (ASL), which uses magnetically labeled water
as a tracer for blood flow. In a recent study, we found
that lower ASL-measured CBF in mild cognitive impairment
(MCI) and Alzheimer’s disease (AD) was associated with worse
performance on the Mini-Mental State Examination (MMSE)
(Binnewijzend et al., 2013). In addition, we found that lower
CBF was related to impairment in multiple cognitive domains
in AD, suggesting CBF as potential functional marker of disease
severity (Leeuwis et al., 2017). However, former studies on
the association between CBF and cognitive functioning have
been limited to cohorts with European-origin participants. Large
differences in the incidence and prevalence of vascular risk
profiles are recognized in ethnic minorities (Anand et al., 2000;
Kurian and Cardarelli, 2007; Gijsberts et al., 2015), but little
is known about how this affects the association between CBF
and cognitive functioning. In the present study, we investigated
the association between ASL-measured CBF with performance
in global cognition and the cognitive domains of memory,
executive functioning/attention and language in a multi-ethnic
community-based cohort with white European, South Asian and
African Caribbean participants.
METHODS
Participants
We analyzed follow-up data from the Southall And Brent
Revisited (SABRE) study, a multi-ethnic community-based
cohort consisting of white European, first-generation migrant
South Asian, and African Caribbean men and women (Tillin
et al., 2012). The SABRE study is a longitudinal study principally
Abbreviations: AD, Alzheimer’s disease; ASL, arterial spin labeling; CBF, cerebral
blood flow; HCT, hematocrit; MCI, mild cognitive impairment; MMSE, Mini-
mental state examination; MRI, magnetic resonance imaging; SABRE, Southall
And Brent Revisited; stß, standardized beta; VCI, vascular cognitive impairment;
WMH, white matter hyperintensities.
investigating cardio-metabolic disease. Index participants were
recruited from primary care between 1988 and 1991, when
they were aged 40–69 years. 4857 participants took part in the
original study (2346 European, 1710 South Asian, 801 African
Caribbean). Surviving participants were invited to attend the
20-year follow-up investigation between 2008 and 2011, and
the 25-year follow-up investigation, which started in 2014 and
was finished in January 2018. One thousand four hundred and
thirty-eight participants attended for clinical follow-up in the 20-
year follow-up investigation (2008–2011). At the 25-year follow-
up investigation (between July 2014 and December 2016), 533
index participants attended the clinical visit [including 197 newly
recruited participants (i.e., partners of index participants and
new African-Caribbean participants)]. Figure 1 is a flow diagram
showing the study population. Participants with available ASL
and neuropsychological assessment during the first phase (July
2014–Dec 2016) of the 25-year follow-up investigation were
included in this cross-sectional analysis. Participants with non-
reliable testing results on neuropsychological assessment, due to
literacy problems, or impaired hearing or eyesight were excluded.
The current study included 452 participants (214 European, 151
South Asian, 87 African Caribbean). Approval was obtained
from Fulham research ethics committee (ref:07/H0712/19) and
all participants gave written informed consent.
Clinical Measurements
Participants had a light breakfast at home (tea or coffee limited
to one cup) and refrained from alcohol and smoking on the
morning of attendance, but took their usual medications on the
clinic morning. Participants completed a questionnaire detailing
sociodemographic characteristics (including years of education),
health behaviors (including smoking status), medical history,
and medication. Height, weight, and waist circumference were
measured (Tillin et al., 2012). Hypertension was defined as
physician diagnosed hypertension or use of blood pressure-
lowering medication from participants’ questionnaire and
general practitioners’ medical record review. Diabetes mellitus
was defined as physician diagnosed diabetes or according to
the World Health Organization 1999 guidelines (World Health
Organization, 1999). Hematocrit (HCT) was measured using an
impedance based, direct current sheath flow method (Sysmex
XE-2100, Sysmex, Kobe, Japan) from a venous blood sample
drawn on the same morning as the MRI examination.
Neuropsychological Assessment
We assessed cognitive functioning with a standardized
neuropsychological test battery. The battery was assessed early in
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FIGURE 1 | Flow diagram, showing our study population. *We excluded 36 participants with non-reliable testing results on neuropsychological assessment, due to
literacy problems, impaired hearing, or impaired eyesight.
the clinic day attendance, to avoid fatigue. The battery comprised
tests previously validated for cross-cultural settings (Stewart
et al., 2001, 2003). We assessed global cognition and the three
cognitive domains of memory, executive functioning/attention
and language. For global cognition, we used the Community
Screening Instrument for Dementia (CSI-D) (Hall et al., 2000;
Prince et al., 2011). To generate a composite global score for
the CSI-D, a standard algorithm was applied (Sosa et al., 2009).
For memory, we used the 10-word total immediate recall and
delayed recall of the Consortium to Establish a Registry for
Alzheimer’s disease (CERAD) (Fillenbaum et al., 1996). We
combined the cognitive domains executive functioning and
attention into one cognitive domain, using the forward and
backward condition of the Digit Span and the Color Trails part
A and B (Wechsler, 1997; Dugbartey et al., 2000; Lee et al., 2000).
To assess language, we used the category fluency (animals)
and the Boston Naming test (Goodglass and Kaplan, 1983).
Raw neuropsychological test scores were standardized into
z-scores. Color Trails A and B were log-transformed due to
non-normal distribution and inverted by computing−1∗z-score,
so that higher scores imply better performance. Subsequently,
available test scores were averaged to create the cognitive
domains.
MRI Protocol
Participants underwent MRI on the same day as all the other
examinations. MRI was performed on a Philips Achieva 3T
scanner (Philips, Best, the Netherlands) using an 8-channel
head coil. The MRI protocol included a sagittal T1-weighted,
T2-weighted, gradient-echo T2∗-weighted, diffusion weighted
images (DWI) and fluid-attenuated inversion recovery (FLAIR)
sequences. Structural MRI images were performed in the same
scanning sessions as transversal 2D pseudo-continuous ASL
(pcASL) perfusion images (EPI, TR/TE 4615/15ms, flip-angle
90◦, voxel size 3.75 × 3.75 × 5mm), 1mm slice gap, 20 slices,
labeling duration 1,800ms, post labeling delay 2,000ms, 35
dynamics). Planning was aligned to the anterior commissure-
posterior commissure line in the transversal plane orthogonal to
the T1w, ensuring coverage of the entire cerebrum including the
vertex.
Brain and Lesion Volumes
An automated segmentation protocol (Geodesic Information
Flows [GIF]) for T1-weighted images was used to yield regional
volumes (Cardoso et al., 2015). GIF is part of the NiftySeg
(http://niftyseg.sf.net) software package and is available at
NiftyWeb (http://cmictig.cs.ucl.ac.uk/niftyweb). A multi-atlas
segmentation propagation and fusion technique, Similarity and
Truth Estimation for Propagated Segmentations (STEPS), was
used to segment in brain structures (Jorge Cardoso et al.,
2013). Hippocampal volumes were calculated as the sum of
right and left segmented volumes. An automated segmentation
method was used to define volumes and distribution of white
matter hyperintensities (WMH). This method is also available at
NiftyWeb.
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Preprocessing and MRI Data Analysis of
ASL
Tissue segmentation and region labels were obtained using
the Geodesic Information Flows framework (Cardoso et al.,
2015). This method produces a state-of-the-art segmentation
and regional labeling by voxel-wise voting between several
propagated atlases, guided by the local image similarity. Gray
matter and white matter were defined within the propagated
atlases. Segmentations of the gray matter, white matter and
cerebrospinal fluid (CSF) space were resampled to the space
of the ASL acquisition making use of the known point-
spread function to account for down-sampling induced loss of
information. Determination of CBF maps from ASL data follows
the simple derived form for pcASL (Equation 1) from the ISMRM
recommendations white paper (Alsop et al., 2014) presented in
units of ml/100 g/min and fitted with an open-source software
package (Melbourne et al., 2016).
CBF = 6000λePLD/T1blood(SC− SL)/SPD(2αT1blood
(1− e−τ/T1blood))[ml/100g/min] (1)
Acquisition proceeded by acquiring a number of pairs of control
(SC) and label (SL) data. These pairs were averaged to generate
single voxel values for the control and label in (Equation 1) where
λ is the plasma/tissue partition coefficient (0.9 ml/g), PLD the
post-labeling delay between end of bolus and start of imaging,
T1blood the blood T1 value (1,650ms), SPD the proton density,
α the labeling efficiency (85%) and τ the labeling pulse duration.
Partial volume correction (PVC) and T1 correction were applied
(Asllani et al., 2008) where the T1 was adapted for HCT using the
formula T1=(0.52∗HCT+0.38)−1 (Lu et al., 2004). The standard
value for blood T1 at 3T is 1,650ms, corresponding to a default
HCT value of about 43%.We used the HCT value measured from
each participant to calculate blood T1.
Statistical Analysis
Statistical analyses were performed using SPSS 22.0 for
Mac (SPSS Inc., Chicago, IL). Participant characteristics for
continuous data are reported as mean ± SD, categorical data
are reported as number (percentage). We performed linear
regression analyses to investigate associations between whole-
brain CBF and cognitive functioning. We used CBF with
correction for individual HCT as the independent variable and
cognitive domains as the dependent variables. We included
age, sex, education and ethnicity as covariates. In addition, we
adjusted for variables that impact CBF and cognitive functioning
in older adults: vascular risk factors (hypertension, diabetes and
smoking) and MRI markers (WMH volume and hippocampal
volume). First, we investigated the association between CBF with
cognitive functioning, adjusted for age and sex (Model 1). We
re-ran this model while one by one adding each of the other
determinants to the model (Models 2–8). Finally, we entered all
variables simultaneously (Model 9). Results were subsequently
stratified for ethnicity. We provide standardized beta’s (stß) to
allow comparison of effect sizes.
RESULTS
Participant Characteristics
Participant characteristics and neuropsychological test results are
shown in Table 1. The mean age of participants was 71 ± 5
years and 174 (38%) were female. White Europeans represented
47% of the sample, South Asians 33% and African Caribbean
19%. Hypertension was highly prevalent (58%), while 23% had
TABLE 1 | Clinical characteristics of participants.
Characteristics Total (n = 452)
Women, n (%) 174 (38.5%)
Ethnicity, n (%)
White European 214 (47%)
South Asian 151 (33%)
African Caribbean 87 (19%)
Age 71 ± 5
Years of education§ 12 ± 3
Hypertension, n (%)
†
262 (58%)
Diabetes mellitus, n (%)
†
105 (23%)
Smoking, n (%)
†§
Never 149 (33%)
Ever 226 (50%)
MRI-characteristics
Left + right hippocampal volume, mL§ 7.1 ± 0.7
Total brain volume, mL 463.4 ± 45.4
Total white matter lesion volume in mL,
median (IQR)§
5.8 (15.5)
Whole-brain HCT CBFU 36.7 ± 6.3
Cognitive test scores
Global cognition (z-score) 0.0 ± 0.7
CSI-D 30.4 ± 1.7
Memory (z-score) 0.0 ± 0.8
CERAD total immediate 18.5 ± 3.9
CERAD delayed 5.7 ± 1.9
Executive functioning/attention (z-score) 0.0 ± 0.7
Digit span (forward) 6.2 ± 1.2
Digit span (backward) 4.1 ± 1.3
Color trails, part A* 68.7 ± 37
Color trials, part B* 148.9 ± 66.9
Language (z-score) 0.0 ± 0.7
Animal fluency 18.9 ± 6.6
Boston naming test¶ 8.6 ± 0.6
MRI, magnetic resonance imaging; CBF, cerebral blood flow; HCT, hematocrit level
correction; IQR, interquartile range; CSI-D, community screening instrument for dementia;
CERAD, consortium to establish a registry for Alzheimer’s disease.
†
History of hypertension, diabetes mellitus and smoking status was determined based on
self-reported medical history and/or medication use.
§Missing values: years of education: 33/452; smoking status 77/452; hippocampal
volume 2/452; white matter lesion volume 27/452.
UCBF-values in mL/100 g/min.
*Higher scores imply worse performance.
¶Boston Naming Test range: 0–9.
Data are presented as mean ± SD or number (percentage). z-scores allow comparison
of neuropsychological test results within participants. Higher z-scores imply better
performance on all tests.
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diabetes mellitus. On average, participants performed within the
normal range on neuropsychological tests.
Association Between Cerebral Blood Flow
and Cognitive Functioning
Table 2 shows the association between CBF and cognitive
functioning, adjusted for age and sex (Model 1). Next, we re-ran
this analysis with additional adjustment for each of the putative
confounders in a separate model (Models 2–8). Adjusted for
age and sex (Model 1), we found associations between CBF and
each of the cognitive domains (standardized beta [stß] = 0.14–
0.18, p < 0.01). Subsequent adjustment for covariates in
Model 2–8 showed that—with exception of ethnicity—none of
the covariates confounded this association. When we finally
entered all variables simultaneously in a multivariate model, we
found that the association between CBF and performance on
executive functioning/attention remained significant (stß= 0.11,
p < 0.05). We found no association between CBF and global
cognition, memory or language. Subsequent stratification for
ethnicity showed that this association was largely attributable
to the white European subgroup. In this group, we found
associations between higher CBF and better performance on
executive functioning/attention (stß = 0.18, p < 0.01) and an
association between CBF and memory (stß = 0.14, p < 0.05).
We found much weaker associations between CBF and cognitive
functioning in the South Asian and African Caribbean group.
Subsequently, we repeated all analyses with partial volume
corrected (PVC) CBF. These analyses showed a similar pattern
of associations (data not shown).
DISCUSSION
In a multi-ethnic community-based cohort we found modest
associations between CBF and cognitive functioning. In
particular, we found an association between higher CBF and
better performance on executive functioning/attention and
memory in the white European group.
Our findings are in line with earlier studies examining CBF
and cognition. For example, the Rotterdam Study investigated
the relationship between CBF using 2D phase-contrast MRI and
cognitive functioning and found small effect sizes for information
processing speed and executive functioning (difference in Z-score
TABLE 2 | Linear regression models for the association between CBF and cognitive functioning.
Group Cognitive domain Model
1 2 3 4 5 6 7 8 9
Age and
sex
Model 1
+
education
Model 1
+
ethnicity
Model 1
+ hyper-
tension
Model 1
+
diabetes
Model 1
+
smoking
Model 1
+ WMH
volume
Model 1
+ hippo-
campal
volume
Full
model (all
variables)
All Global cognition 0.18** 0.18*** 0.07 0.15** 0.16** 0.15** 0.17** 0.16** 0.06
(n = 452) Memory 0.15*** 0.14** 0.11* 0.14** 0.14** 0.12* 0.15* 0.14** 0.06
Executive func/attention 0.17*** 0.16** 0.09* 0.15* 0.15** 0.18*** 0.18*** 0.16** 0.11*
Language 0.14** 0.13* 0.03 0.12* 0.13** 0.10 0.13** 0.13** −0.02
European Global cognition 0.12 0.11 n.a. 0.11 0.11 0.13 0.12 0.11 0.14
(n = 215) Memory 0.13* 0.12* n.a. 0.13* 0.13* 0.13* 0.14* 0.13* 0.14*
Executive fun /attention 0.18** 0.18** n.a. 0.18** 0.18** 0.19** 0.17* 0.18** 0.18**
Language 0.01 0.00 n.a. 0.01 0.01 0.01 −0.01 0.00 −0.02
South Asian Global cognition 0.04 0.06 n.a. 0.03 0.04 −0.01 0.04 0.04 0.00
(n = 151) Memory 0.07 0.07 n.a. 0.05 0.07 −0.06 0.08 0.07 −0.05
Executive func/attention −0.01 −0.04 n.a. −0.03 −0.01 0.02 0.05 −0.01 −0.01
Language −0.00 0.01 n.a. −0.01 −0.00 −0.04 −0.02 0.01 −0.07
African
Caribbean
Global cognition 0.04 0.04 n.a. 0.01 0.01 0.04 −0.06 0.05 −0.11
(n = 87) Memory 0.05 0.02 n.a. 0.04 0.02 −0.02 −0.01 0.04 −0.15
Executive func/attention 0.04 −0.01 n.a. 0.02 0.04 0.10 0.02 0.05 0.05
Language −0.10 0.10 n.a. 0.08 0.07 0.03 0.10 0.10 0.02
Executive func, executive functioning; WMH, white matter hyperintensities; n.a., not applicable. *p < 0.05, **p < 0.01, ***p < 0.001. Results are presented as standardized beta [stß] to
allow comparison of effect sizes. We used linear regression analyses with cerebral blood flow (CBF) as independent variable and cognitive domains as dependent variable. Cognition is
expressed as (composite) z-score. Model 1: Univariate regression analysis, adjusted for age and sex; Model 2–8: All analyses are adjusted for age and sex + named variable; Model 9:
We entered all variables (age, sex, education, ethnicity, vascular risk factors and MRI measures) simultaneously in one model (Enter method). Results were subsequently stratified for
ethnicity.
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per SD increase in flowmeasure: 0.04 (CI:−0.02;−0.09) and 0.00
(CI: −0.05; 0.05) respectively) (Poels et al., 2008). In addition,
a study of the association between CBF and cognitive decline
found a modest effect size on lower CBF and accelerated decline
in global cognition (ß=−0.029) (Wolters et al., 2017).
Previously, we investigated the association between CBF and
cognitive functioning in a memory clinic cohort and we found
effect sizes comparable to the current study (stß = 0.09–0.14,
all p < 0.05). Stratification for syndrome diagnosis (cognitively
normal, MCI and dementia) showed that this association was
mainly attributable to the dementia group and was least obvious
in the cognitively normal group (stß = 0.01–0.07, all p >
0.05). These findings support the potential role of ASL as
measure of disease severity, as we found only an association
in the dementia group. In the current study we did find a
significant albeit modest association between CBF and cognition
in a community-based population. We previously investigated
CBF in the predementia phase of AD and we found that CBF
alterations occur further along the disease process of AD and
were only reduced in more advanced stages of AD (Binnewijzend
et al., 2015). In combination with the current results, this would
suggest that changes in ASL-measured CBF are less sensitive
in the early stages of cognitive impairment and dementia.
In addition, our modest results might be attributable to the
comparatively high prevalence of adverse vascular risk factors
in this multi-ethnic study of older adults. Earlier studies suggest
that reduced CBF is a major factor in the development of
vascular cognitive impairment (VCI) (Sabayan et al., 2012; Yang
et al., 2017). In a former study we showed that decreased CBF
in a memory clinic cohort not only reflects disease burden of
neurodegeneration, but is also related to small vessel disease
(SVD) and (cerebro-)vascular factors (Benedictus et al., 2014).
The most prominent finding was the association between CBF
and executive functioning/attention. This is consistent with the
observation that executive dysfunction is common in patients
with VCI(Prins and Scheltens, 2015). In addition, we also found
an association with memory. However, although cognitive tests
are selected to measure a specific cognitive domain, most tests
involve multiple cognitive processes. For example, the CERAD
(verbal memory test) not only measures memory but also
requires attention and executive control in list organization.
Consistent with our findings, effect sizes of the relations between
vascular brain injury and cognitive functioning in cognitively
normal elderly are generally modest. For example, a recent
meta-analysis on the association between WMH and cognitive
functioning showed small effect sizes for memory and executive
functioning/attention (Fisher z-score −0.08 [CI: −0.13; −0.06]
and −0.11 [CI: −0.16; −0.07] respectively) (Kloppenborg et al.,
2014). In addition, a recent meta-analysis on the effect of
microbleeds showed a small negative association with global
cognitive functioning (individuals with microbleeds−0.3 MMSE
point lower than those without; Li et al., 2017).
Among the limitations of the study is its cross-sectional
design, which prevents us from drawing conclusions about
causality. We cannot exclude potential survival bias as the least
healthy participants were less likely to participate in the 25-
year follow-up study, used for the current study. Second, we
found that common vascular risk factors do not confound the
associations between CBF and cognition, while ethnicity acted
as a confounder. It is known that vascular risk factors increase
the risk of cognitive impairment and are associated with reduced
CBF (Gorelick et al., 2011; Muller et al., 2012). Reduced CBF
has been associated with poorer cognitive performance in older
patients with high vascular risk, suggesting that older adults with
multiple risk factors may be particularly vulnerable to cognitive
changes as a function of reduced CBF (Bangen et al., 2014).
Contrary to our expectation, our results could not be attributed
to South Asian and African Caribbean participants having higher
burden of vascular risk factors, although there may have been
other group differences not accounted for in our analyses.
In addition, we did not adjust for possible confounders such as
caffeine-intake and vasoactive medication. The Rotterdam Study
recently showed that hippocampal subregions, in particular the
subiculum, were associated with cognitive functioning, over
and above that of total hippocampal volume (Evans et al.,
2018). Our study showed that total hippocampal volume did
not confound the association between CBF and cognitive
functioning. Unfortunately, we did not have information on
hippocampal subregions in this study. The relatively small sample
size of the South Asian and African Caribbean subgroups could
indicate lack of adequate statistical power to reveal associations.
Alternatively, the neuropsychological test battery which has
been validated for cross-cultural settings (Nguyen et al., 2007;
Robertson et al., 2007) may not have been sensitive enough to
detect specific or subtle cognitive deficits in this community-
based cohort. Furthermore, literacy influences the specificity
of neuropsychological measures but is also a strong factor
in determining level of cognitive functioning. We excluded
participants with obvious literacy problems from our analyses,
but suboptimal literacy and numeracy in our cohort could have
influenced our results.
The main strengths of our study were the large ethnically
diverse community-based cohort, the use of a standardized
ASL-MRI protocol and a standardized neuropsychological test
battery. We used individualized HCT adjusted CBF estimates.
A recent study in this cohort showed that HCT levels differed
according to sex and ethnicity and that this influenced the CBF
estimates (Smith et al., under review). In our study, analyses
with adjustment for partial volume yielded comparable results,
confirming that our findings were not confounded by cerebral
atrophy.
In summary, we have shown modest associations between
CBF and cognitive functioning in a cohort of multi-ethnic elderly
with a high prevalence of cardiovascular risk factors. These
findings support the notion that CBF is less sensitive to early
brain changes and has particular value in more advanced disease
stages of dementia.
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